Literature DB >> 11921053

Age-related disability in multiple sclerosis.

Maria Trojano1, Maria Liguori, Giovanni Bosco Zimatore, Roberto Bugarini, Carlo Avolio, Damiano Paolicelli, Fabrizio Giuliani, Francesca De Robertis, Maria Giovanna Marrosu, Paolo Livrea.   

Abstract

There is evidence that the clinical course of multiple sclerosis is age related. The present study evaluated the relationship between age and rate of disability progression in a large hospital-based cohort of definite cases of multiple sclerosis (n= 1,463). Patients were followed every 6 to 12 months for a total period of observation of 11,387.8 person-years. Expanded Disability Status Scale scores increased significantly with increasing current age and longer duration of disease (p=0.007). Median times to reach Expanded Disability Status Scale scores of 4.0 and 6.0, assessed using an extended Kaplan-Meier method with age as a categorical time-varying covariate, were significantly longer among patients aged 20 to 35 years compared with patients aged 36 to 50 and 51 to 65 years (p < 0.0001). Significant associations were observed between mean Expanded Disability Status Scale scores and age at disease onset, current age, and the interaction of age at disease onset and current age (p < 0.001). Current age had a greater effect (59% of variability in the model) on disease severity than did age at disease onset. Furthermore, a multiplicative effect on Expanded Disability Status Scale score was observed for age at disease onset and current age combined, indicating a faster rate of disease progression in older patients. In conclusion, the results of the current study demonstrate the impact of age on rate of disability progression in multiple sclerosis and suggest that an age-adjusted progression index may be a more relevant criterion for defining differences between multiple sclerosis groups.

Entities:  

Mesh:

Year:  2002        PMID: 11921053     DOI: 10.1002/ana.10147

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  Relapses and disability accumulation in progressive multiple sclerosis.

Authors:  M Mateo Paz Soldán; Martina Novotna; Nuhad Abou Zeid; Nilufer Kale; Melih Tutuncu; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; B Mark Keegan; Istvan Pirko; Sean J Pittock; Claudia F Lucchinetti; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci
Journal:  Neurology       Date:  2014-11-14       Impact factor: 9.910

2.  Clinical characteristics of multiple sclerosis in Västerbotten County in northern Sweden.

Authors:  P Sundström; A Svenningsson; L Nyström; L Forsgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

3.  Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Authors:  Francesco Patti; Maria Pia Amato; Stefano Bastianello; Luisa Caniatti; Elisabetta Di Monte; Fausto Lijoi; Benedetta Goretti; Silvia Messina; Orietta Picconi; Maria Rosalia Tola; Maria Trojano
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

4.  European validation of a standardized clinical description of multiple sclerosis.

Authors:  Maria Pia Amato; Jerome Grimaud; Iuliana Achiti; Maria Letizia Bartolozzi; Patrice Adeleine; Hans-Peter Hartung; Ludwig Kappos; Alan Thompson; Maria Trojano; Sandra Vukusic; Christian Confavreux
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

5.  Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.

Authors:  Muhammad Taimur Malik; Brian C Healy; Leslie A Benson; Pia Kivisakk; Alexander Musallam; Howard L Weiner; Tanuja Chitnis
Journal:  Neurology       Date:  2014-05-21       Impact factor: 9.910

6.  Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.

Authors:  Alexa K Stuifbergen; Shelley Blozis; Heather Becker; Tracie Harrison; Vicki Kullberg
Journal:  Disabil Health J       Date:  2016-01-28       Impact factor: 2.554

7.  Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors.

Authors:  Jane L Wetzel; Donna K Fry; Lucinda A Pfalzer
Journal:  Physiother Can       Date:  2011-04-13       Impact factor: 1.037

8.  Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Authors:  Melih Tutuncu; Junger Tang; Nuhad Abou Zeid; Nilufer Kale; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; Sean J Pittock; Istvan Pirko; B Mark Keegan; Claudia F Lucchinetti; John H Noseworthy; Moses Rodriguez; Brian G Weinshenker; Orhun H Kantarci
Journal:  Mult Scler       Date:  2012-06-26       Impact factor: 6.312

9.  Lateral ventricular cerebrospinal fluid diffusivity as a potential neuroimaging marker of brain temperature in multiple sclerosis: a hypothesis and implications.

Authors:  Khader M Hasan; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Magn Reson Imaging       Date:  2014-12-05       Impact factor: 2.546

10.  Age-related changes in grey and white matter structure throughout adulthood.

Authors:  Antonio Giorgio; Luca Santelli; Valentina Tomassini; Rose Bosnell; Steve Smith; Nicola De Stefano; Heidi Johansen-Berg
Journal:  Neuroimage       Date:  2010-03-06       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.